207 related articles for article (PubMed ID: 18816637)
1. Novel biomarkers for risk of prostate cancer: results from a case-control study.
Yang L; Gaikwad NW; Meza J; Cavalieri EL; Muti P; Trock B; Rogan EG
Prostate; 2009 Jan; 69(1):41-8. PubMed ID: 18816637
[TBL] [Abstract][Full Text] [Related]
2. Potential biomarker for early risk assessment of prostate cancer.
Markushin Y; Gaikwad N; Zhang H; Kapke P; Rogan EG; Cavalieri EL; Trock BJ; Pavlovich C; Jankowiak R
Prostate; 2006 Oct; 66(14):1565-71. PubMed ID: 16894534
[TBL] [Abstract][Full Text] [Related]
3. Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma.
Gaikwad NW; Yang L; Weisenburger DD; Vose J; Beseler C; Rogan EG; Cavalieri EL
Biomarkers; 2009 Nov; 14(7):502-12. PubMed ID: 19863189
[TBL] [Abstract][Full Text] [Related]
4. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
Cavalieri E; Rogan E
Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
[TBL] [Abstract][Full Text] [Related]
5. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
[TBL] [Abstract][Full Text] [Related]
6. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.
Todorovic R; Devanesan P; Higginbotham S; Zhao J; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2001 Jun; 22(6):905-11. PubMed ID: 11375897
[TBL] [Abstract][Full Text] [Related]
7. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
Cavalieri E; Rogan E
Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
[TBL] [Abstract][Full Text] [Related]
8. The molecular etiology of breast cancer: evidence from biomarkers of risk.
Gaikwad NW; Yang L; Muti P; Meza JL; Pruthi S; Ingle JN; Rogan EG; Cavalieri EL
Int J Cancer; 2008 May; 122(9):1949-57. PubMed ID: 18098283
[TBL] [Abstract][Full Text] [Related]
9. Unbalanced estrogen metabolism in thyroid cancer.
Zahid M; Goldner W; Beseler CL; Rogan EG; Cavalieri EL
Int J Cancer; 2013 Dec; 133(11):2642-9. PubMed ID: 23686454
[TBL] [Abstract][Full Text] [Related]
10. Urine biomarkers of risk in the molecular etiology of breast cancer.
Gaikwad NW; Yang L; Pruthi S; Ingle JN; Sandhu N; Rogan EG; Cavalieri EL
Breast Cancer (Auckl); 2009 Jan; 3():1-8. PubMed ID: 21556245
[TBL] [Abstract][Full Text] [Related]
11. Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease.
Cavalieri EL; Rogan EG; Zahid M
Int J Cancer; 2017 Sep; 141(6):1078-1090. PubMed ID: 28388839
[TBL] [Abstract][Full Text] [Related]
12. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones.
Cavalieri EL; Rogan EG
Ann N Y Acad Sci; 2004 Dec; 1028():247-57. PubMed ID: 15650250
[TBL] [Abstract][Full Text] [Related]
13. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition.
Lu F; Zahid M; Saeed M; Cavalieri EL; Rogan EG
J Steroid Biochem Mol Biol; 2007; 105(1-5):150-8. PubMed ID: 17582757
[TBL] [Abstract][Full Text] [Related]
14. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.
Zahid M; Kohli E; Saeed M; Rogan E; Cavalieri E
Chem Res Toxicol; 2006 Jan; 19(1):164-72. PubMed ID: 16411670
[TBL] [Abstract][Full Text] [Related]
15. Unbalanced estrogen metabolism in ovarian cancer.
Zahid M; Beseler CL; Hall JB; LeVan T; Cavalieri EL; Rogan EG
Int J Cancer; 2014 May; 134(10):2414-23. PubMed ID: 24170413
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation.
Zahid M; Saeed M; Lu F; Gaikwad N; Rogan E; Cavalieri E
Free Radic Biol Med; 2007 Dec; 43(11):1534-40. PubMed ID: 17964424
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
[TBL] [Abstract][Full Text] [Related]
19. Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol.
Saeed M; Rogan E; Fernandez SV; Sheriff F; Russo J; Cavalieri E
Int J Cancer; 2007 Apr; 120(8):1821-4. PubMed ID: 17230531
[TBL] [Abstract][Full Text] [Related]
20. Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?
Cavalieri EL; Rogan EG
IUBMB Life; 2010 Oct; 62(10):746-51. PubMed ID: 20945454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
